Actively Recruiting

Age: 18Years +
All Genders
NCT05489783

Glioma Developmental and HyperActive Ras Tumor (DHART) Board

Led by Memorial Sloan Kettering Cancer Center · Updated on 2025-06-29

50

Participants Needed

7

Research Sites

209 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will collect medical records, scan results, and complete surveys to create a registry about people with a neurofibromatosis type 1-associated brain tumor (NF1-associated glioma). A registry is a collection of health information about individuals, and it is usually focused on a specific diagnosis or condition. This registry study will help the researchers learn more about the diagnosis, treatment, and quality of life of people with NF1-associated glioma. The researchers want to understand what happens as a result of different treatments for NF1-associated glioma and how these treatments and the disease itself affect people's lives over a period of time. Information collected during this study could affect how doctors diagnose, test, and treat NF1-associated glioma, and the study could help future patients with this type of cancer.

CONDITIONS

Official Title

Glioma Developmental and HyperActive Ras Tumor (DHART) Board

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinical diagnosis meeting NIH criteria for NF1 by documented record or supported self-report
  • Willing to have historical and future NF1-related health records sent to the registry
  • Radiologic or pathologically confirmed glioma
  • 18 years of age or older at the time of consent
Not Eligible

You will not qualify if you...

  • Unwilling to sign informed consent
  • Not proficient in English or Spanish as determined by the Investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 7 locations

1

Memorial Sloan Kettering Basking Ridge (All Protocol Activities)

Basking Ridge, New Jersey, United States, 07920

Actively Recruiting

2

Memorial Sloan Kettering Monmouth (All protocol activities)

Middletown, New Jersey, United States, 07748

Actively Recruiting

3

Memorial Sloan Kettering Bergen (All Protocol Activities)

Montvale, New Jersey, United States, 07645

Actively Recruiting

4

Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)

Commack, New York, United States, 11725

Actively Recruiting

5

Memorial Sloan Kettering West Harrison (All Protocol Activities)

Harrison, New York, United States, 10604

Actively Recruiting

6

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

New York, New York, United States, 10065

Actively Recruiting

7

Memorial Sloan Kettering Nassau (All Protocol Activities)

Rockville Centre, New York, United States, 11570

Actively Recruiting

Loading map...

Research Team

A

Anna Piotrowski, MD

CONTACT

I

Ingo Mellinghoff, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Glioma Developmental and HyperActive Ras Tumor (DHART) Board | DecenTrialz